Selected research
Market Analysis & Forecast
Global Sonidegib Market Analysis and Forecast 2026-2032
Market perspective
The global Sonidegib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sonidegib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Sonidegib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Sonidegib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Sonidegib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Sonidegib include Sun Pharmaceutical Industries and Novartis etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Sonidegib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Sonidegib, also provides the sales of main regions and countries. Of the upcoming market potential for Sonidegib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sonidegib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sonidegib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sonidegib sales, projected growth trends, production technology, application and end-user industry.
Sonidegib Segment by Company
Sun Pharmaceutical Industries
Novartis
Sonidegib Segment by Type
Solution
Capsule
Sonidegib Segment by Application
Treating Basal Cell Carcinoma
Antitumor
Others
Sonidegib Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sonidegib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sonidegib and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sonidegib.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Sonidegib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sonidegib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sonidegib sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solution
- Capsule
Applications
- Treating Basal Cell Carcinoma
- Antitumor
- Others
Companies covered
- Sun Pharmaceutical Industries
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Sonidegib Market by Type
- 1.2.1 Global Sonidegib Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Solution
- 1.2.3 Capsule
- 1.3 Sonidegib Market by Application
- 1.3.1 Global Sonidegib Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Treating Basal Cell Carcinoma
- 1.3.3 Antitumor
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sonidegib Market Dynamics
- 2.1 Sonidegib Industry Trends
- 2.2 Sonidegib Industry Drivers
- 2.3 Sonidegib Industry Opportunities and Challenges
- 2.4 Sonidegib Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Sonidegib Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Sonidegib Revenue by Region
- 3.2.1 Global Sonidegib Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Sonidegib Revenue by Region (2021-2026)
- 3.2.3 Global Sonidegib Revenue by Region (2027-2032)
- 3.2.4 Global Sonidegib Revenue Market Share by Region (2021-2032)
- 3.3 Global Sonidegib Sales Estimates and Forecasts 2021-2032
- 3.4 Global Sonidegib Sales by Region
- 3.4.1 Global Sonidegib Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Sonidegib Sales by Region (2021-2026)
- 3.4.3 Global Sonidegib Sales by Region (2027-2032)
- 3.4.4 Global Sonidegib Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Sonidegib Revenue by Manufacturers
- 4.1.1 Global Sonidegib Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Sonidegib Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Sonidegib Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Sonidegib Sales by Manufacturers
- 4.2.1 Global Sonidegib Sales by Manufacturers (2021-2026)
- 4.2.2 Global Sonidegib Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Sonidegib Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Sonidegib Sales Price by Manufacturers (2021-2026)
- 4.4 Global Sonidegib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Sonidegib Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Sonidegib Manufacturers, Product Type & Application
- 4.7 Global Sonidegib Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Sonidegib Market CR5 and HHI
- 4.8.2 2025 Sonidegib Tier 1, Tier 2, and Tier 3
5 Sonidegib Market by Type
- 5.1 Global Sonidegib Revenue by Type
- 5.1.1 Global Sonidegib Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Sonidegib Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Sonidegib Revenue Market Share by Type (2021-2032)
- 5.2 Global Sonidegib Sales by Type
- 5.2.1 Global Sonidegib Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Sonidegib Sales by Type (2021-2032) & (Units)
- 5.2.3 Global Sonidegib Sales Market Share by Type (2021-2032)
- 5.3 Global Sonidegib Price by Type
6 Sonidegib Market by Application
- 6.1 Global Sonidegib Revenue by Application
- 6.1.1 Global Sonidegib Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Sonidegib Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Sonidegib Revenue Market Share by Application (2021-2032)
- 6.2 Global Sonidegib Sales by Application
- 6.2.1 Global Sonidegib Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Sonidegib Sales by Application (2021-2032) & (Units)
- 6.2.3 Global Sonidegib Sales Market Share by Application (2021-2032)
- 6.3 Global Sonidegib Price by Application
7 Company Profiles
- 7.1 Sun Pharmaceutical Industries
- 7.1.1 Sun Pharmaceutical Industries Company Information
- 7.1.2 Sun Pharmaceutical Industries Business Overview
- 7.1.3 Sun Pharmaceutical Industries Sonidegib Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sun Pharmaceutical Industries Sonidegib Product Portfolio
- 7.1.5 Sun Pharmaceutical Industries Recent Developments
- 7.2 Novartis
- 7.2.1 Novartis Company Information
- 7.2.2 Novartis Business Overview
- 7.2.3 Novartis Sonidegib Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Novartis Sonidegib Product Portfolio
- 7.2.5 Novartis Recent Developments
8 North America
- 8.1 North America Sonidegib Market Size by Type
- 8.1.1 North America Sonidegib Revenue by Type (2021-2032)
- 8.1.2 North America Sonidegib Sales by Type (2021-2032)
- 8.1.3 North America Sonidegib Price by Type (2021-2032)
- 8.2 North America Sonidegib Market Size by Application
- 8.2.1 North America Sonidegib Revenue by Application (2021-2032)
- 8.2.2 North America Sonidegib Sales by Application (2021-2032)
- 8.2.3 North America Sonidegib Price by Application (2021-2032)
- 8.3 North America Sonidegib Market Size by Country
- 8.3.1 North America Sonidegib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Sonidegib Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Sonidegib Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Sonidegib Market Size by Type
- 9.1.1 Europe Sonidegib Revenue by Type (2021-2032)
- 9.1.2 Europe Sonidegib Sales by Type (2021-2032)
- 9.1.3 Europe Sonidegib Price by Type (2021-2032)
- 9.2 Europe Sonidegib Market Size by Application
- 9.2.1 Europe Sonidegib Revenue by Application (2021-2032)
- 9.2.2 Europe Sonidegib Sales by Application (2021-2032)
- 9.2.3 Europe Sonidegib Price by Application (2021-2032)
- 9.3 Europe Sonidegib Market Size by Country
- 9.3.1 Europe Sonidegib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Sonidegib Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Sonidegib Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Sonidegib Market Size by Type
- 10.1.1 China Sonidegib Revenue by Type (2021-2032)
- 10.1.2 China Sonidegib Sales by Type (2021-2032)
- 10.1.3 China Sonidegib Price by Type (2021-2032)
- 10.2 China Sonidegib Market Size by Application
- 10.2.1 China Sonidegib Revenue by Application (2021-2032)
- 10.2.2 China Sonidegib Sales by Application (2021-2032)
- 10.2.3 China Sonidegib Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Sonidegib Market Size by Type
- 11.1.1 Asia Sonidegib Revenue by Type (2021-2032)
- 11.1.2 Asia Sonidegib Sales by Type (2021-2032)
- 11.1.3 Asia Sonidegib Price by Type (2021-2032)
- 11.2 Asia Sonidegib Market Size by Application
- 11.2.1 Asia Sonidegib Revenue by Application (2021-2032)
- 11.2.2 Asia Sonidegib Sales by Application (2021-2032)
- 11.2.3 Asia Sonidegib Price by Application (2021-2032)
- 11.3 Asia Sonidegib Market Size by Country
- 11.3.1 Asia Sonidegib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Sonidegib Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Sonidegib Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Sonidegib Market Size by Type
- 12.1.1 SAMEA Sonidegib Revenue by Type (2021-2032)
- 12.1.2 SAMEA Sonidegib Sales by Type (2021-2032)
- 12.1.3 SAMEA Sonidegib Price by Type (2021-2032)
- 12.2 SAMEA Sonidegib Market Size by Application
- 12.2.1 SAMEA Sonidegib Revenue by Application (2021-2032)
- 12.2.2 SAMEA Sonidegib Sales by Application (2021-2032)
- 12.2.3 SAMEA Sonidegib Price by Application (2021-2032)
- 12.3 SAMEA Sonidegib Market Size by Country
- 12.3.1 SAMEA Sonidegib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Sonidegib Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Sonidegib Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Sonidegib Value Chain Analysis
- 13.1.1 Sonidegib Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Sonidegib Production Mode & Process
- 13.2 Sonidegib Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Sonidegib Distributors
- 13.2.3 Sonidegib Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst